Sergio Abrignani

Endostart SRL manufactures medical devices for gastrointestinal endoscopy. It specializes in medical devices based on ferrofluid and magnetic fields to guide a colonoscope along the colon, avoiding incomplete colonoscopies. The company was founded by Alessandro Tozzi on May 1, 2018 and is headquartered in Certaldo, Italy.

Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.

Vivasure Medical Ltd. manufactures medical devices to enable deployment of vascular implants. It offers an absorbable implant and delivery system for use in a range of medical applications, primarily in minimally invasive and percutaneous procedures, such as percutaneous closure of arteriotomies. The company was founded by Gerard Brett and Christopher Martin on August 27, 2008 and is headquartered in Galway, Ireland.

CID SpA engages in the manufacture and marketing of medical devices. Its products include peripheral vascular stents, closed system catheters, and vascular grafts. The company was founded in 2008 and is headquartered in Saluggia, Italy.

Aileens Pharma Srl is a holding company, which engages in the research and development of treatments for dermatological diseases. The company was founded by Sonia Longo Sormani in 2018 and is headquartered in Nova Milanese, Italy.

InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy.

Knoll International SpA designs and manufactures home & office furniture and furnishings products. The company was founded in 1938 and is headquartered in Milan, Italy.

Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy.

Biovelocita Srl (Biovelocita) is a venture capital firm founded in 2015 by Silvano Spinelli, Gabriella Camboni and Sofinnova Partners. The firm is headquartered in Milan, Italy.

Amypopharma Srl develops therapeutic solutions for protein disorders. It specializes in functionalized nanoliposomes to treat protein misfolding disorders. The company was founded by Massimo Ernesto Masserini and Francesca Re in 2015 and is headquartered in Milan, Italy.

Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy.

Ri.Tra.Ma Rink Trading & Manufacturing SpA engages in the manufacture and distribution of self-adhesive materials. Its products include roll labels, graphics, offset sheets, papers, boards, industrial tapes, and polyester fiber sheets. The company was founded by Arnold Rink in 1962 and is headquartered in Caponago, Italy.

Praesidium SGR SpA is a private equity firm. The private company is based in Milan, Italy.

Opera SGR SpA is an Independent Private Equity firm founded in 2004. The firm is headquartered in Milan.

Assietta Private Equity SGR SpA (Assietta Private Equity) is a private equity subsidiary of Asietta SpA founded in 2000. The firm is headquartered in Milan, Italy.

Sapio Produzione Idrogeno Ossigeno Srl engages in the manufacture and distribution of industrial gases. It offers technical gas, pure and special gases and mixtures, refrigerant gas, food gas, liquefied petroleum and natural gas, welding gas, and gas for laser cutting. The company was founded in 1922 and is headquartered in Monza, Italy.

Betaglue Technologies SpA is a holding company, which engages in the provision of medical technology and oncology research services. The company was founded by Francesco Izzo and is headquartered in Naples, Italy.

BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands.

360° Capital Partners SAS (360° Capital Partners) is a venture capital firm founded in 1997. The firm is headquartered in Paris, France.

Electro Power Systems SpA engages in the engineering, manufacturing, and installation of hydrogen-based systems for energy storage. The company was founded by Emilio Paolucci, Ilaria Rosso, and Adriano Marconetto on January 25, 2005 and is headquartered in Turin, Italy.

Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy.

Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland.

Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France.

BioRep S.r.l is a private company based in Milan, Italy. BioRep is a centro di risorse biologiche, which translates to a biological resources center. The Italian company was founded in 2003. Gervasoni Vincenzo has been the CEO of the company since 2010.

Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California.

Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021.

Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware.

Abintus Bio, Inc. operates as a preclinical stage gene therapy company. It provides immune cell reprogramming services. The company was founded by John Snyder, Nicholas A. Boyle, Douglas J. Jolly, Carlos Ibañez, Derek Ostertag, and Cory Bentley and is headquartered in Encinitas, CA.

Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA.